Yudi Xiong

Wuhan, 430079, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer.

HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer.

Journal: Cellular signalling

Published: May 25, 2026

Machine Learning-Based Ultrasound Radiomics Signature: A Retrospective Analysis for Differentiating Benign from Malignant Non-Mass Lesions in Dense Breasts.

Machine Learning-Based Ultrasound Radiomics Signature: A Retrospective Analysis for Differentiating Benign from Malignant Non-Mass Lesions in Dense Breasts.

Journal: International journal of general medicine

Published: January 15, 2026

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation.

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation.

Journal: Journal of clinical medicine

Published: January 29, 2023

A novel function for cyclin D1 as a transcriptional role in oncogenesis and tumor development by ChIP-Seq and RNA-Seq.

A novel function for cyclin D1 as a transcriptional role in oncogenesis and tumor development by ChIP-Seq and RNA-Seq.

Journal: Journal of Cancer

Published: September 06, 2020

Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis.

Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: May 28, 2020

Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.

Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: October 08, 2019

Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report.

Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report.

Journal: Journal of medical case reports

Published: August 31, 2019

Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer.

Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer.

Journal: Signal transduction and targeted therapy

Published: August 31, 2019

Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.

Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: July 21, 2019

Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.

Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: February 02, 2019

Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.

Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 31, 2018

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.

Journal: Oncotarget

Published: May 29, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026